| 期 |
栏目 |
标题 |
文件 |
| 卷 30, 编号 8 (2023) |
Reviews |
Molecular genetic aspects of the development of atopic dermatitis |
|
| 卷 30, 编号 8 (2023) |
Pharmacological properties of drugs |
Expert Council Resolution “The place of quifenadine in the treatment of allergic diseases and the classification of antihistamines” |
|
| 卷 30, 编号 14 (2023) |
Pulmonology/ENT/ARVI |
Modern ideas about the combination of bronchial asthma and chronic obstructive pulmonary disease |
|
| 卷 31, 编号 1 (2024) |
Pulmonology/ENT/ARVI |
Phenotype of bronchial asthma with fixed obstruction |
|
| 卷 31, 编号 1 (2024) |
Pulmonology/ENT/ARVI |
Triple therapy in the treatment of patients with a combination of chronic obstructive pulmonary disease and bronchial asthma |
|
| 卷 31, 编号 1 (2024) |
Dermatology/allergology |
Filaggrin as a biomarker of exacerbation of atopic dermatitis during pregnancy |
|
| 卷 31, 编号 3 (2024) |
Original articles |
Evaluation of cytokines in nasal secretions in children with bronchial asthma and concomitant upper respiratory tract pathology |
|
| 卷 31, 编号 6 (2024) |
Pediatria |
Investigation of transforming growth factor β1 in induced sputum and nasal secretion in children with bronchial asthma |
|
| 卷 31, 编号 6 (2024) |
Dermatology/allergology |
The role of Substance P in the pathogenesis and treatment of some skin diseases |
|
| 卷 32, 编号 7 (2025) |
Reviews |
The role of skin microbiota in the development of atopic dermatitis in pregnant women and their newborns: prospects for diagnosis and therapy |
|
| 卷 32, 编号 7 (2025) |
Reviews |
The role of intestinal microbiota in the development of atopic dermatitis |
|
